Visigen

Visigen Biotechnologies was a genomics company focused on developing a next-generation, real-time, single-molecule DNA sequencing platform. The company's technology utilized fluorescence resonance energy transfer (FRET) between a polymerase and a nucleotide to identify bases in real-time. Founded in 2000 and based in Houston, Texas, Visigen aimed to significantly reduce the cost and increase the speed of whole-genome sequencing. In 2008, the company was acquired by Life Technologies (now part of Thermo Fisher Scientific) to bolster its portfolio of sequencing technologies. Its innovations contributed to the evolution of high-throughput genomic analysis tools used in modern molecular biology.